Cullinan Therapeutics, Inc. (CGEM)

NASDAQ

$16.30

+$0.57 (3.62%)

Today

No price data available for this timeframe.

Key Statistics

Day Range

$15.54$16.43

Open $15.92

52 Week Range

$5.68$16.74

Previous Close $15.73

Market Cap929.27M

Volume845.25K

Avg Volume889.27K

P/E (TTM)-4.14

EPS (TTM)$-3.67

Dividend / YieldN/A

Dividend StreakN/A

About Cullinan Therapeutics, Inc.

Cullinan Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the developing of oncology and immuno-oncology therapies. Its pipeline includes CLN-978, CLN-619, Zipalertinib CLN-081/TAS6417, CLN-049, and CLN-617. The company was founded by Patrick A. Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA.

Company Info

SectorHealthcare

IndustryMedical - Pharmaceuticals

CEONadim Ahmed

Employees111

Websitecullinantherapeutics.com

Trading Information

Open

$15.92

Previous Close

$15.73

Day High

$16.43

Day Low

$15.54

52 Week High

$16.74

52 Week Low

$5.68